The Joint Corp. (NASDAQ: JYNT) reported Q4 EPS of ($0.75), $0.76 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $30.6 million versus the consensus estimate of $29.08 million.

GUIDANCE:

The Joint Corp. sees FY2024 revenue of $530-545 million.
System-wide comp sales for all clinics open 13 months or more are expected to be in the mid-single digits in 2024.
2024 new franchised clinic openings, excluding the impact of refranchised clinics, are expected to be between 60 and 75, compared to 104 in 2023.

For earnings history and earnings-related data on The Joint Corp. (JYNT) click here.